youtube_live
Q3 2026 earnings • released • EPS beat +2.32% • Revenue miss -0.16%
See resultschevron_right
ALC:NYSE
Alcon AG
$71.86
arrow_downward
-2.97%(-2.20) 1D
Nov 11, 12:53:16 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$71.70
High
$72.34
Low
$70.34
Mkt. cap
29.69B
Avg. vol.
1.98M
Volume
2.88M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$71.70
High
$72.34
Low
$70.34
Mkt. cap
29.69B
Avg. vol.
1.98M
Volume
2.88M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
finchannel
·
1 hour ago
Alcon shares fall as lens competition and tariff refund cloud earnings growth
TradingView
·
1 hour ago
Alcon AG reports results for the quarter ended September 30 - Earnings Summary
Investing.com
·
3 hours ago
Alcon Q3 2026 presentation: EPS beats forecast, shares fall on revenue
Investing.com
·
3 hours ago
Earnings call transcript: Alcon Q3 2026 beats EPS but shares fall 4.6%
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com